Sean McGowan

Stock Analyst at Roth Capital

(1.24)
# 1908
Out of 5,358 analysts
60
Total ratings
44.44%
Success rate
5.53%
Average return
17 Stocks
Name Action PT Current % Upside Ratings Updated
NAGE Niagen Bioscience
Maintains: Strong Buy
10 23
12.94 77.74% 1 Jun 6, 2025
MNST Monster Beverage
Maintains: Neutral
50 56
63.43 -11.71% 7 May 14, 2025
GRPN Groupon
Maintains: Strong Buy
21 24
32.95 -27.16% 7 Apr 29, 2025
CELH Celsius Holdings
Reiterates: Buy
38 38
40.57 -6.33% 14 Feb 21, 2025
SNYR Synergy CHC
Initiates Coverage On: Buy
10
2.1 376.19% 1 Jan 21, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
65 60
28.29 112.09% 7 Dec 23, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
6 8
n/a n/a 4 Nov 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
1 1
3.7 -72.97% 3 Sep 3, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
20
14.62 36.8% 1 Sep 3, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
5 5
0.85 488.24% 4 Aug 19, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Strong Buy
25 26
n/a n/a 3 Aug 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
5 4
n/a n/a 2 Apr 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
5
1.98 127.27% 1 Feb 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
3
0.86 248.84% 2 Sep 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
3
n/a n/a 1 Aug 29, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
17 7
n/a n/a 1 Aug 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
3
n/a n/a 1 Oct 1, 2021